Adult ADHD has gained significant recognition in recent years, driven largely by social media discussions and a growing awareness of its various presentations.

Traditionally, ADHD was seen primarily as a condition affecting hyperactive boys in elementary school, but its understanding has evolved.

A recent report from the CDC indicates that nearly half of the estimated 15.5 million adults in the U.S. diagnosed with ADHD received their diagnosis in adulthood.

Telemedicine has emerged as a crucial method for managing ADHD, with around 50% of diagnosed adults utilizing these services, although many face medication refill issues due to shortages.

The pandemic led to relaxed regulations by the DEA, facilitating easier access to stimulant medications like Adderall and Ritalin through telehealth.

However, concerns have surfaced regarding the over-prescription of ADHD medications by telehealth companies, particularly allegations against Done for inappropriate practices.

Critics argue that online tests and questionnaires for diagnosing ADHD often use vague statements that could apply to many, raising questions about their validity.

Complicating the diagnosis of ADHD is the overlap between its symptoms and those of burnout, such as lack of motivation and distraction.

This has led to a debate about whether ADHD is being overdiagnosed or underdiagnosed, especially among marginalized groups like African American and Latinx children and women.

Some evidence suggests that many adults self-diagnosing ADHD may actually be neurotypical, highlighting the complexity of the condition.

Amidst these discussions, the concept of neurodiversity is gaining traction, emphasizing the unique cognitive differences in individuals with ADHD.

In response to the rising demand for ADHD diagnoses and treatments, the National Health Service in Britain has established a new taskforce to manage the influx.